236 related articles for article (PubMed ID: 27272157)
1. Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer.
Wu J; Xue X; Zhang B; Cao H; Kong F; Jiang W; Li J; Sun D; Guo R
Tumour Biol; 2016 Sep; 37(9):12301-12313. PubMed ID: 27272157
[TBL] [Abstract][Full Text] [Related]
2. The protective effects of paeonol against epirubicin-induced hepatotoxicity in 4T1-tumor bearing mice via inhibition of the PI3K/Akt/NF-kB pathway.
Wu J; Xue X; Zhang B; Jiang W; Cao H; Wang R; Sun D; Guo R
Chem Biol Interact; 2016 Jan; 244():1-8. PubMed ID: 26646421
[TBL] [Abstract][Full Text] [Related]
3. Cardioprotective effect of paeonol against epirubicin-induced heart injury via regulating miR-1 and PI3K/AKT pathway.
Wu J; Sun C; Wang R; Li J; Zhou M; Yan M; Xue X; Wang C
Chem Biol Interact; 2018 Apr; 286():17-25. PubMed ID: 29505745
[TBL] [Abstract][Full Text] [Related]
4. The Antitumor Mechanism of Paeonol on CXCL4/CXCR3-B Signals in Breast Cancer Through Induction of Tumor Cell Apoptosis.
Saahene RO; Wang J; Wang ML; Agbo E; Pang D
Cancer Biother Radiopharm; 2018 Aug; 33(6):233-240. PubMed ID: 29847158
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of paeonol and cisplatin on oesophageal cancer cell lines.
Wan XA; Sun GP; Wang H; Xu SP; Wang ZG; Liu SH
Dig Liver Dis; 2008 Jul; 40(7):531-9. PubMed ID: 18339596
[TBL] [Abstract][Full Text] [Related]
6. Paeonol alleviates epirubicin-induced renal injury in mice by regulating Nrf2 and NF-κB pathways.
Wu J; Xu L; Sun C; Zhang B; Li J; Sun J; Zhang Y; Sun D
Eur J Pharmacol; 2017 Jan; 795():84-93. PubMed ID: 27940053
[TBL] [Abstract][Full Text] [Related]
7. Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor.
Shi J; Li J; Li J; Li R; Wu X; Gao F; Zou L; Mak WWS; Fu C; Zhang J; Leung GP
Phytomedicine; 2021 Jan; 81():153408. PubMed ID: 33234363
[TBL] [Abstract][Full Text] [Related]
8. Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway.
Cao J; Tong C; Liu Y; Wang J; Ni X; Xiong MM
Biomed Pharmacother; 2017 Dec; 96():450-458. PubMed ID: 29031204
[TBL] [Abstract][Full Text] [Related]
9. Paeonol exerts an anticancer effect on human colorectal cancer cells through inhibition of PGE₂ synthesis and COX-2 expression.
Li M; Tan SY; Wang XF
Oncol Rep; 2014 Dec; 32(6):2845-53. PubMed ID: 25322760
[TBL] [Abstract][Full Text] [Related]
10. Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma.
Zhang SH; Zhang H; He HW; Li L; Li XQ; Zhang YP; Shao RG
Cancer Chemother Pharmacol; 2013 Oct; 72(4):777-88. PubMed ID: 23975242
[TBL] [Abstract][Full Text] [Related]
11. Berberine and Evodiamine Act Synergistically Against Human Breast Cancer MCF-7 Cells by Inducing Cell Cycle Arrest and Apoptosis.
Du J; Sun Y; Lu YY; Lau E; Zhao M; Zhou QM; Su SB
Anticancer Res; 2017 Nov; 37(11):6141-6151. PubMed ID: 29061795
[TBL] [Abstract][Full Text] [Related]
12. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects.
Li J; Wu Y; Wang D; Zou L; Fu C; Zhang J; Leung GP
Pharmacol Res; 2019 Aug; 146():104313. PubMed ID: 31202781
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.
El-Naa MM; Othman M; Younes S
Drug Des Devel Ther; 2016; 10():3661-3672. PubMed ID: 27895461
[TBL] [Abstract][Full Text] [Related]
14. The use of functional epirubicin liposomes to induce programmed death in refractory breast cancer.
Liu L; Mu LM; Yan Y; Wu JS; Hu YJ; Bu YZ; Zhang JY; Liu R; Li XQ; Lu WL
Int J Nanomedicine; 2017; 12():4163-4176. PubMed ID: 28615943
[TBL] [Abstract][Full Text] [Related]
15. Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways.
Zhang L; Tao L; Shi T; Zhang F; Sheng X; Cao Y; Zheng S; Wang A; Qian W; Jiang L; Lu Y
IUBMB Life; 2015 Oct; 67(10):778-88. PubMed ID: 26452780
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV enhances taxol chemosensitivity of breast cancer via caveolin-1-targeting oxidant damage.
Zheng Y; Dai Y; Liu W; Wang N; Cai Y; Wang S; Zhang F; Liu P; Chen Q; Wang Z
J Cell Physiol; 2019 Apr; 234(4):4277-4290. PubMed ID: 30146689
[TBL] [Abstract][Full Text] [Related]
17. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells.
Pal HC; Baxter RD; Hunt KM; Agarwal J; Elmets CA; Athar M; Afaq F
Oncotarget; 2015 Sep; 6(29):28296-311. PubMed ID: 26299806
[TBL] [Abstract][Full Text] [Related]
18. Paeonol exerts anti‑tumor activity against colorectal cancer cells by inducing G0/G1 phase arrest and cell apoptosis via inhibiting the Wnt/β‑catenin signaling pathway.
Liu LH; Shi RJ; Chen ZC
Int J Mol Med; 2020 Aug; 46(2):675-684. PubMed ID: 32626954
[TBL] [Abstract][Full Text] [Related]
19. Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer.
Jiang PD; Zhao YL; Deng XQ; Mao YQ; Shi W; Tang QQ; Li ZG; Zheng YZ; Yang SY; Wei YQ
Biomed Pharmacother; 2010 Nov; 64(9):609-14. PubMed ID: 20888174
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo assessments of two novel hydrazide compounds against breast cancer as well as mammary tumor cells.
Mousavi E; Tavakolfar S; Almasirad A; Kooshafar Z; Dehghani S; Afsharinasab A; Amanzadeh A; Shafiee S; Salimi M
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1195-1203. PubMed ID: 28451832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
